| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Diagnostics and Genetics |
Departments of1 Chemical Pathology, 2 Paediatrics, 3 Medicine and Therapeutics, and 4 Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China
aAddress correspondence to this author at: Department of Chemical Pathology, The Chinese University of Hong Kong, Room 38023, 1/F Clinical Sciences Bldg., Prince of Wales Hospital, 30-32 Ngan Shing St., Shatin, New Territories, Hong Kong Special Administrative Region, China. E-mail loym{at}cuhk.edu.hk.
Background: The availability of an early diagnostic tool for severe acute respiratory syndrome (SARS) would have major public health implications. We investigated whether the SARS coronavirus (SARS-CoV) can be detected in serum and plasma samples during the early stages of SARS and studied the potential prognostic implications of such an approach.
Methods: We developed two real-time quantitative reverse transcription-PCR (RT-PCR) assays, one for the polymerase and the other for the nucleocapsid region of the virus genome, for measuring the concentration of SARS-CoV RNA in serum/plasma samples from SARS patients. Plasma samples were obtained from 12 confirmed SARS patients on the day of hospital admission, as well as on days 7 and 14 after fever onset. Serum samples were also obtained from 23 confirmed SARS patients on the day of hospital admission, 11 of whom subsequently required intensive care. Viral RNA was extracted from the plasma/serum samples. The extracted RNA was subjected to analysis by the RT-PCR assays.
Results: The RT-PCR system for the polymerase region detected SARS-CoV RNA in 50% of plasma and 78% of serum samples from SARS patients during the first week of illness. The detection rates for plasma dropped to 25% at day 14 after fever onset. The median serum SARS-CoV concentrations in patients who required and did not require intensive care unit admission during the course of hospitalization were 5800 and 140 copies/mL, respectively (Mann–Whitney test, P <0.005). These data were confirmed by the RT-PCR system for the nucleocapsid region, which showed an even higher detection rate of 87%. The correlation between the results obtained by the two RT-PCR systems was high (Pearson correlation analysis, r = 0.998; P <0.001).
Conclusion: Plasma/serum SARS-CoV quantification represents a potentially useful early diagnostic and prognostic tool for SARS.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  J. Dong, J. P. Olano, J. W. McBride, and D. H. Walker Emerging Pathogens: Challenges and Successes of Molecular Diagnostics J. Mol. Diagn., May 1, 2008; 10(3): 185 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, R. M.Y. Wong, S. S.C. Chim, S. M. Ngai, J. J.Y. Sung, et al. Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome Clin. Chem., March 1, 2006; 52(3): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L.-S. Tang, P. K.-S. Chan, C.-K. Wong, K.-F. To, A. K.-L. Wu, Y.-M. Sung, D. S.-C. Hui, J. J.-Y. Sung, and C. W.-K. Lam Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome Clin. Chem., December 1, 2005; 51(12): 2333 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Vijgen, E. Keyaerts, E. Moes, P. Maes, G. Duson, and M. Van Ranst Development of One-Step, Real-Time, Quantitative Reverse Transcriptase PCR Assays for Absolute Quantitation of Human Coronaviruses OC43 and 229E J. Clin. Microbiol., November 1, 2005; 43(11): 5452 - 5456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Yip, S. S. T. To, P. H.M. Leung, T. S. Cheung, P. K.C. Cheng, and W. W.L. Lim Use of Dual TaqMan Probes to Increase the Sensitivity of 1-Step Quantitative Reverse Transcription-PCR: Application to the Detection of SARS Coronavirus Clin. Chem., October 1, 2005; 51(10): 1885 - 1888. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kan, M. Wang, H. Jing, H. Xu, X. Jiang, M. Yan, W. Liang, H. Zheng, K. Wan, Q. Liu, et al. Molecular Evolution Analysis and Geographic Investigation of Severe Acute Respiratory Syndrome Coronavirus-Like Virus in Palm Civets at an Animal Market and on Farms J. Virol., September 15, 2005; 79(18): 11892 - 11900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Ho, P. H. Chau, P. S. F. Yip, G. C. Ooi, P. L. Khong, J. C. Ho, P. C. Wong, C. Ko, C. Yan, and K. W. Tsang A prediction rule for clinical diagnosis of severe acute respiratory syndrome Eur. Respir. J., September 1, 2005; 26(3): 474 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Greenough, A. Carville, J. Coderre, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, and K. Mansfield Pneumonitis and Multi-Organ System Disease in Common Marmosets (Callithrix jacchus) Infected with the Severe Acute Respiratory Syndrome-Associated Coronavirus Am. J. Pathol., August 1, 2005; 167(2): 455 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, B. Bai, Z. Hu, Z. Chen, X. An, L. Tang, J. Yang, H. Wang, and H. Wang Development and Evaluation of a Multitarget Real-Time Taqman Reverse Transcription-PCR Assay for Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus and Surveillance for an Apparently Related Coronavirus Found in Masked Palm Civets J. Clin. Microbiol., May 1, 2005; 43(5): 2041 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I-J. Liu, P.-J. Chen, S.-H. Yeh, Y.-P. Chiang, L.-M. Huang, M.-F. Chang, S.-Y. Chen, P.-C. Yang, S.-C. Chang, W.-K. Wang, et al. Immunofluorescence Assay for Detection of the Nucleocapsid Antigen of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Cells Derived from Throat Wash Samples of Patients with SARS J. Clin. Microbiol., May 1, 2005; 43(5): 2444 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S C C Wong, J K C Chan, K C Lee, E S F Lo, and D N C Tsang Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens J. Clin. Pathol., March 1, 2005; 58(3): 276 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-K. Wang, C.-T. Fang, H.-L. Chen, C.-F. Yang, Y.-C. Chen, M.-L. Chen, S.-Y. Chen, J.-Y. Yang, J.-H. Lin, P.-C. Yang, et al. Detection of Severe Acute Respiratory Syndrome Coronavirus RNA in Plasma during the Course of Infection J. Clin. Microbiol., February 1, 2005; 43(2): 962 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Kang, Y. Xu, X. Wu, Y. Liang, C. Wang, J. Guo, Y. Wang, M. Chen, D. Wu, Y. Wang, et al. Proteomic Fingerprints for Potential Application to Early Diagnosis of Severe Acute Respiratory Syndrome Clin. Chem., January 1, 2005; 51(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T.C. Yip, J. W.M. Chan, W. C.S. Cho, T.-T. Yip, Z. Wang, T.-L. Kwan, S. C.K. Law, D. N.C. Tsang, J. K.C. Chan, K.-C. Lee, et al. Protein Chip Array Profiling Analysis in Patients with Severe Acute Respiratory Syndrome Identified Serum Amyloid A Protein as a Biomarker Potentially Useful in Monitoring the Extent of Pneumonia Clin. Chem., January 1, 2005; 51(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.W. Tsang, G.C. Ooi, and P.L. Ho Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt? Eur. Respir. J., December 1, 2004; 24(6): 1025 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Chu, L. L.M. Poon, V. C.C. Cheng, K.-S. Chan, I. F.N. Hung, M. M.L. Wong, K.-H. Chan, W.-S. Leung, B. S.F. Tang, V. L. Chan, et al. Initial viral load and the outcomes of SARS Can. Med. Assoc. J., November 23, 2004; 171(11): 1349 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Leung, T. H. Rainer, F.-L. Lau, I. O.L. Wong, A. Tong, T.-W. Wong, J. H.B. Kong, A. J. Hedley, T.-H. Lam, and for the Hospital Authority SARS Collaborative Grou A Clinical Prediction Rule for Diagnosing Severe Acute Respiratory Syndrome in the Emergency Department Ann Intern Med, September 7, 2004; 141(5): 333 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S.C. Hui and J. J.Y. Sung Treatment of Severe Acute Respiratory Syndrome Chest, September 1, 2004; 126(3): 670 - 674. [Full Text] [PDF]
|
|
|
|
|
|
T. C.W. Poon, K.C. A. Chan, P.-C. Ng, R. W.K. Chiu, I. L. Ang, Y.-k. Tong, E. K.O. Ng, F. W.T. Cheng, A. M. Li, E. K.L. Hon, et al. Serial Analysis of Plasma Proteomic Signatures in Pediatric Patients with Severe Acute Respiratory Syndrome and Correlation with Viral Load Clin. Chem., August 1, 2004; 50(8): 1452 - 1455. [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, Y. Mao, L. Ju, J. Zhang, Z. Liu, X. Zhou, Q. Li, Y. Wang, S. Kim, and L. Zhang Detection and Monitoring of SARS Coronavirus in the Plasma and Peripheral Blood Lymphocytes of Patients with Severe Acute Respiratory Syndrome Clin. Chem., July 1, 2004; 50(7): 1237 - 1240. [Full Text] [PDF]
|
|
|
|
 |
|
 D S C Hui, M C H Chan, A K Wu, and P C Ng Severe acute respiratory syndrome (SARS): epidemiology and clinical features Postgrad. Med. J., July 1, 2004; 80(945): 373 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Choy, S.-G. Lin, P. K.-S. Chan, J. S.-L. Tam, Y.M. D. Lo, I. M.-T. Chu, S.-N. Tsai, M.-Q. Zhong, K.-P. Fung, M. M.-Y. Waye, et al. Synthetic Peptide Studies on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Glycoprotein: Perspective for SARS Vaccine Development Clin. Chem., June 1, 2004; 50(6): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K.O. Ng, P.-C. Ng, K.L. E. Hon, W.T. F. Cheng, E. C.W. Hung, K.C. A. Chan, R. W.K. Chiu, A. M. Li, L. L.M. Poon, D. S. Hui, et al. Serial Analysis of the Plasma Concentration of SARS Coronavirus RNA in Pediatric Patients with Severe Acute Respiratory Syndrome Clin. Chem., December 1, 2003; 49(12): 2085 - 2088. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
